afib and semaglutide GLP-1 drugs outperform SGLT-2 drugs for patients with type 2 diabetes Metabolic remodelling in atrial fibrillation:
Description
Both oral and injectable GLP-1 therapies can cause nausea, constipation, or diarrhea, particularly during dose escalation
1 2 3 4 Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Rnnholm H, Wikstrm L (February 2008)
Nausea typically peaks in week one or two, then improves as your system adapts
however, it is worth noting that normal-tissue protein annotation is pending, meaning RNA data do not confirm protein presence or function
Why Combine Semaglutide and Orlistat
